American Journal of Neuroradiology 28:371-377, February 2007
© 2007 American Society of Neuroradiology
INTERVENTIONAL
Endovascular Treatment of Intracranial Arteriovenous Malformations with Onyx: Technical Aspects
a Department of Radiology and Neuroradiology, Alfried Krupp Krankenhaus, Essen, Germany
b Department of Neurology, Alfried Krupp Krankenhaus, Essen, Germany
c Department of Psychiatry and Psychotherapy, University of Duisburg-Essen, Essen, Germany
d Department of Neuroradiology, Justus Liebig University, Giessen, Germany
Address correspondence to Dr. med. Bernhard Kis, Department of Psychiatry, University of Duisburg-Essen, Rheinische Kliniken Essen, Research Unit, Virchow Str 174, D-45147 Essen, Germany; e-mail: bernhard.kis{at}uni-duisburg-essen.de
BACKGROUND AND PURPOSE: We report our experiences in the treatment of intracranial arteriovenous malformations (AVMs) with Onyx embolization before neuro- or radiosurgery, focusing on the embolization technique with Onyx.
METHODS: Ninety-three patients (40 women and 53 men, mean age 38 years) with 94 intracranial AVMs with a mean volume of 9.2 mL were embolized with Onyx. The following features of all AVMs were evaluated before the treatment: type of nidus and shunt, draining veins, and feeding arteries.
RESULTS: Complete obliteration rates were 20% at the end of all embolization steps and 53% after embolization and surgery. In 21% of patients the final control angiography is not yet available (after surgery 9%, after radiosurgery 12%). In 4% of patients, radiosurgery was planned due to a persistent arteriovenous shunt. The injection of Onyx resulted in high occlusion rates (volume reduction >90%) when the AVM was in a supratentorial and cortical location, the nidus was compact and plexiform, and when there was a small number of supplying (direct) feeders and one superficial draining vein. Access devicerelated complications (stuck catheter, vessel perforation) occurred during the embolization of 220 feeding arteries in 6% of patients, with all such instances having had no clinical consequences.
CONCLUSION: With knowledge of the morphologic characteristics of AVMs that are suitable for a treatment with Onyx, high occlusion rates and low complication rates in treating a small number of feeders are feasible. Superselective intranidal or perinidal catheter positions and slow, controlled injections that protect the draining veins make the therapy safe even in complex AVMs and critical locations.
This article has been cited by other articles:
![]() |
M.C. Hurley, B.A. Gross, D. Surdell, A. Shaibani, K. Muro, C.M. Mitchell, E.M. Doppenberg, and B.R. Bendok Preoperative Onyx Embolization of Aggressive Vertebral Hemangiomas AJNR Am. J. Neuroradiol., June 1, 2008; 29(6): 1095 - 1097. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.G. Nogueira, G. Dabus, J.D. Rabinov, C.J. Eskey, C.S. Ogilvy, J.A. Hirsch, and J.C. Pryor Preliminary Experience with Onyx Embolization for the Treatment of Intracranial Dural Arteriovenous Fistulas AJNR Am. J. Neuroradiol., January 1, 2008; 29(1): 91 - 97. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Friedlander Arteriovenous Malformations of the Brain N. Engl. J. Med., June 28, 2007; 356(26): 2704 - 2712. [Full Text] [PDF] |
||||

